Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Tramadol 5 mg/mL vs Contramal 100 mg/mL
NCT05716763Phase 1Completed
- Sponsor
- Unither Pharmaceuticals
- Start
- Feb 2023
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tramadol in pain (2 arms), sponsored by Unither Pharmaceuticals. Primary endpoints: Maximum Plasma Concentration at 24.00 hours and Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration at 24.00 hours. Started Feb 2023; status: completed.
02
Drugs
tramadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT05716763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05716763.